Literature DB >> 12638567

The impact of Acinetobacter baumannii in the intensive care unit.

C Theaker1, B Azadian, N Soni.   

Abstract

Acinetobacter baumannii is a significant problem in critically ill patients. It is widespread, can colonise patients quickly and causes virulent infections. However, its overall impact on morbidity and mortality in the critically ill remains unmeasured. This study was designed to investigate A. baumannii colonisation and infection rates in a critically ill population over an 18-month period. Twenty-seven patients from a population of 347 were identified as having A. baumannii. Sixteen were colonised, whereas 11 were infected. Eleven of the 27 patients with A. baumannii died (41%). Of these, eight were colonised and three were infected. In the same period, 320 patients did not have A. baumannii and their mortality rate was 20% (n = 64). The mortality rate of patients with A. baumannii was significantly higher than that of patients without infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638567     DOI: 10.1046/j.1365-2044.2003.30403.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Judith Glover; Juliana M Coelho; Marina Warner; Rachel Pike; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.

Authors:  Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

3.  Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.

Authors:  Jaeyeong Park; Eunkyoung Shin; Ji-Hyun Yeom; Younkyung Choi; Minju Joo; Minho Lee; Je Hyeong Kim; Jeehyeon Bae; Kangseok Lee
Journal:  J Microbiol       Date:  2021-12-29       Impact factor: 3.422

4.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017.

Authors:  Susannah L McKay; Nicholas Vlachos; Jonathan B Daniels; Valerie S Albrecht; Valerie A Stevens; J Kamile Rasheed; J Kristie Johnson; Joseph D Lutgring; Maria Sjölund-Karlsson; Alison Laufer Halpin
Journal:  Microb Drug Resist       Date:  2022-05-27       Impact factor: 2.706

5.  Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.

Authors:  Michele Iacono; Laura Villa; Daniela Fortini; Roberta Bordoni; Francesco Imperi; Raoul J P Bonnal; Thomas Sicheritz-Ponten; Gianluca De Bellis; Paolo Visca; Antonio Cassone; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

6.  Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan.

Authors:  Yohei Doi; Jun-Ichi Wachino; Kunikazu Yamane; Naohiro Shibata; Tetsuya Yagi; Keigo Shibayama; Haru Kato; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

7.  Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airways.

Authors:  Jose Antonio Méndez; Jesús Mateos; Alejandro Beceiro; María Lopez; María Tomás; Margarita Poza; Germán Bou
Journal:  BMC Genomics       Date:  2015-05-30       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.